Cargando…
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma
In serum, the major part of vascular endothelial growth factor derives from in vitro degranulation of granulocytes and platelets. Therefore, plasma may be preferred for vascular endothelial growth factor measurements. However, which specimen is the best predictor of survival is still debated. The pr...
Autores principales: | Werther, K, Christensen, I J, Nielsen, H J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375229/ https://www.ncbi.nlm.nih.gov/pubmed/11875709 http://dx.doi.org/10.1038/sj.bjc.6600075 |
Ejemplares similares
-
Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer
por: Salgado, R, et al.
Publicado: (2002) -
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
por: Bachelot, T, et al.
Publicado: (2003) -
Prognostic significance of dysadherin expression in advanced colorectal carcinoma
por: Aoki, S, et al.
Publicado: (2003) -
Overexpression of VEGF(121), but not VEGF(165) or FGF-1, improves oxygenation in MCF-7 breast tumours
por: Fenton, B M, et al.
Publicado: (2004) -
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)
por: Dales, J P, et al.
Publicado: (2004)